Literature DB >> 29089605

Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.

Marry M van den Heuvel-Eibrink1, Janna A Hol1, Kathy Pritchard-Jones2, Harm van Tinteren3, Rhoikos Furtwängler4, Arnauld C Verschuur5, Gordan M Vujanic6, Ivo Leuschner7, Jesper Brok2, Christian Rübe8, Anne M Smets9, Geert O Janssens1,10, Jan Godzinski11,12, Gema L Ramírez-Villar13, Beatriz de Camargo14, Heidi Segers15, Paola Collini16, Manfred Gessler17, Christophe Bergeron18, Filippo Spreafico16, Norbert Graf4.   

Abstract

The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP-RTSG) has developed a new protocol for the diagnosis and treatment of childhood renal tumours, the UMBRELLA SIOP-RTSG 2016 (the UMBRELLA protocol), to continue international collaboration in the treatment of childhood renal tumours. This protocol will support integrated biomarker and imaging research, focussing on assessing the independent prognostic value of genomic changes within the tumour and the volume of the blastemal component that survives preoperative chemotherapy. Treatment guidelines for Wilms tumours in the UMBRELLA protocol include recommendations for localized, metastatic, and bilateral disease, for all age groups, and for relapsed disease. These recommendations have been established by a multidisciplinary panel of leading experts on renal tumours within the SIOP-RTSG. The UMBRELLA protocol should promote international collaboration and research and serve as the SIOP-RTSG best available treatment standard.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29089605     DOI： 10.1038/nrurol.2017.163

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


  53 in total

1.  Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial.

Authors:  J de Kraker; N Graf; H van Tinteren; F Pein; B Sandstedt; J Godzinski; M F Tournade
Journal:  Lancet       Date:  2004 Oct 2-8       Impact factor: 79.321

2.  Malignant renal tumours incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project.

Authors:  Guido Pastore; Ariana Znaor; Filippo Spreafico; Norbert Graf; Kathy Pritchard-Jones; Eva Steliarova-Foucher
Journal:  Eur J Cancer       Date:  2006-09       Impact factor: 9.162

3.  Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.

Authors:  M F Tournade; C Com-Nougué; J de Kraker; R Ludwig; A Rey; J M Burgers; B Sandstedt; J Godzinski; M Carli; R Potter; J M Zucker
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

4.  Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital.

Authors:  Jeffrey S Dome; Tiebin Liu; Matthew Krasin; Lennie Lott; Patricia Shearer; Najat C Daw; Catherine A Billups; Judith A Wilimas
Journal:  J Pediatr Hematol Oncol       Date:  2002 Mar-Apr       Impact factor: 1.289

5.  Bilateral Wilms tumors (WT) treated with the SIOP 93 protocol in France: epidemiological survey and patient outcome.

Authors:  Hélène Sudour; George Audry; Gudrun Schleimacher; Catherine Patte; Sophie Dussart; Christophe Bergeron
Journal:  Pediatr Blood Cancer       Date:  2012-01-11       Impact factor: 3.167

6.  Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.

Authors:  Christopher Mitchell; Kathy Pritchard-Jones; Rosemary Shannon; Carolyn Hutton; Suzanne Stevens; David Machin; John Imeson; Anna Kelsey; Gordan M Vujanic; Peter Gornall; Jenny Walker; Roger Taylor; Pat Sartori; Juliet Hale; Gill Levitt; Boo Messahel; Helen Middleton; Richard Grundy; Jon Pritchard
Journal:  Eur J Cancer       Date:  2006-08-10       Impact factor: 9.162

7.  Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study.

Authors:  G J D'Angio; N Breslow; J B Beckwith; A Evans; H Baum; A deLorimier; D Fernbach; E Hrabovsky; B Jones; P Kelalis
Journal:  Cancer       Date:  1989-07-15       Impact factor: 6.860

8.  Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity.

Authors:  A Weirich; R Ludwig; N Graf; U Abel; I Leuschner; G M Vujanic; O Mehls; J Boos; J Beck; B Royer-Pokora; P A Voûte
Journal:  Ann Oncol       Date:  2004-05       Impact factor: 32.976

9.  Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy.

Authors:  Arnauld Verschuur; Harm Van Tinteren; Norbert Graf; Christophe Bergeron; Bengt Sandstedt; Jan de Kraker
Journal:  J Clin Oncol       Date:  2012-08-27       Impact factor: 44.544

10.  Ifosfamide is an active drug in Wilms' tumor: a phase II study conducted by the French Society of Pediatric Oncology.

Authors:  M F Tournade; J Lemerle; M Brunat-Mentigny; C Bachelot; H Roche; O Taboureau; D Olive; O Lejars; A Boilletot; F Demeocq
Journal:  J Clin Oncol       Date:  1988-05       Impact factor: 44.544
View more
  46 in total

1.  [Imaging of abdominal tumors in childhood and adolescence : Part II: relevant intra-abdominal and retroperitoneal tumor entities].

Authors:  D M Renz; H-J Mentzel
Journal:  Radiologe       Date:  2018-07       Impact factor: 0.635

2.  Interobserver variability between experienced and inexperienced observers in the histopathological analysis of Wilms tumors: a pilot study for future algorithmic approach.

Authors:  Jikke J Rutgers; Tessa Bánki; Ananda van der Kamp; Tomas J Waterlander; Marijn A Scheijde-Vermeulen; Marry M van den Heuvel-Eibrink; Jeroen A W M van der Laak; Marta Fiocco; Annelies M C Mavinkurve-Groothuis; Ronald R de Krijger
Journal:  Diagn Pathol       Date:  2021-08-21       Impact factor: 2.644

Review 3.  [Tumor predisposition syndromes and nephroblastoma : Early diagnosis with imaging].

Authors:  N Welter; R Furtwängler; G Schneider; N Graf; J-P Schenk
Journal:  Radiologie (Heidelb)       Date:  2022-08-25

4.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

5.  International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and Study.

Authors:  Joaquim Caetano de Aguirre-Neto; Beatriz de Camargo; Harm van Tinteren; Christophe Bergeron; Jesper Brok; Gema Ramírez-Villar; Arnauld Verschuur; Rhoikos Furtwängler; Lisa Howell; Daniel Saunders; Oystein Olsen; Aurore Coulomb; Christian Vokuhl; Jan Godzinski; Anne M Smets; Gordan M Vujanic; Marry M van den Heuvel-Eibrink; Norbert Graf; Kathy Pritchard-Jones
Journal:  JCO Glob Oncol       Date:  2022-05

Review 6.  Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocol.

Authors:  Saskia L Gooskens; Norbert Graf; Rhoikos Furtwängler; Filippo Spreafico; Christophe Bergeron; Gema L Ramírez-Villar; Jan Godzinski; Christian Rübe; Geert O Janssens; Gordan M Vujanic; Ivo Leuschner; Aurore Coulomb-L'Hermine; Anne M Smets; Beatriz de Camargo; Sara Stoneham; Harm van Tinteren; Kathy Pritchard-Jones; Marry M van den Heuvel-Eibrink
Journal:  Nat Rev Urol       Date:  2018-02-27       Impact factor: 14.432

7.  Wilms tumour in children: 18 years of experience at Vilnius University Hospital Santaros Klinikos, Lithuania.

Authors:  Milda Rančelytė; Rolanda Nemanienė; Lina Ragelienė; Jelena Rascon
Journal:  Acta Med Litu       Date:  2019

8.  Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle study.

Authors:  Ruben Van Paemel; Andries De Koker; Charlotte Vandeputte; Lieke van Zogchel; Tim Lammens; Geneviève Laureys; Jo Vandesompele; Gudrun Schleiermacher; Mathieu Chicard; Nadine Van Roy; Ales Vicha; G A M Tytgat; Nico Callewaert; Katleen De Preter; Bram De Wilde
Journal:  Epigenetics       Date:  2020-07-14       Impact factor: 4.528

9.  Robotic Surgery in Pediatric Oncology: Lessons Learned from the First 100 Tumors-A Nationwide Experience.

Authors:  Thomas Blanc; Pierre Meignan; Nicolas Vinit; Quentin Ballouhey; Luca Pio; Carmen Capito; Caroline Harte; Fabrizio Vatta; Louise Galmiche-Rolland; Véronique Minard; Daniel Orbach; Laureline Berteloot; Cécile Muller; Jules Kohaut; Aline Broch; Karim Braik; Aurélien Binet; Yves Heloury; Laurent Fourcade; Hubert Lardy; Sabine Sarnacki
Journal:  Ann Surg Oncol       Date:  2021-09-14       Impact factor: 5.344

10.  Open versus minimally-invasive surgical techniques in pediatric renal tumors: A population-level analysis of in-hospital outcomes.

Authors:  Kirsten L Simmons; Jason C Chandrapal; Steven Wolf; Henry E Rice; Elisabeth E Tracy; Tamara Fitzgerald; Gina-Maria Pomann; Jonathan C Routh
Journal:  J Pediatr Urol       Date:  2021-03-19       Impact factor: 1.921
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.